Literature DB >> 11308254

Variation in the E2-binding domain of HPV 16 is associated with high-grade squamous intraepithelial lesions of the cervix.

A Giannoudis1, M Duin, P J Snijders, C S Herrington.   

Abstract

Human papillomaviruses (HPV) are strongly associated with cervical intraepithelial neoplasia (CIN) and invasive cancer mainly through the action of the E6 and E7 viral proteins, transcription of which is down-regulated by the E2 protein. To test the hypothesis that HPV 16 E2 variation is important in the development of high-grade squamous neoplasia of the cervix, we carried out a cross-sectional analysis of low-grade and high-grade squamous intraepithelial lesions (SILs) for specific mutations in the HPV 16 E2 gene and for E2 gene disruption in these regions. Isolates were also analysed for the HPV 16 350T-G variant. 22 of 178 low-grade SILs and 43 of 61 high-grade SILs examined, contained HPV 16. No relationship was found between the E6 350T-G variant, or the E2 hinge region 3410C-T variant, and lesion grade. However, disruption of the regions of E2 analysed was significantly more frequent in high-grade lesions, and there was a significant association between the 3684C-A variant in the E2 DNA binding domain and high-grade histology suggesting that this variant may be important in progression to high-grade intraepithelial disease. Copyright 2001 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11308254      PMCID: PMC2363853          DOI: 10.1054/bjoc.2001.1695

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis.

Authors:  M Kalantari; F Karlsen; G Kristensen; R Holm; B Hagmar; B Johansson
Journal:  Int J Gynecol Pathol       Date:  1998-04       Impact factor: 2.762

2.  Structural analysis of the human papillomavirus type 16-E2 transactivator with antipeptide antibodies reveals a high mobility region linking the transactivation and the DNA-binding domains.

Authors:  J M Gauthier; J Dillner; M Yaniv
Journal:  Nucleic Acids Res       Date:  1991-12       Impact factor: 16.971

3.  Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis.

Authors:  M van Duin; P J Snijders; M T Vossen; E Klaassen; F Voorhorst; R H Verheijen; T J Helmerhorst; C J Meijer; J M Walboomers
Journal:  J Gen Virol       Date:  2000-02       Impact factor: 3.891

4.  Asian-american variants of human papillomavirus type 16 have extensive mutations in the E2 gene and are highly amplified in cervical carcinomas.

Authors:  L Casas; S C Galvan; R M Ordoñez; N Lopez; M Guido; J Berumen
Journal:  Int J Cancer       Date:  1999-11-12       Impact factor: 7.396

5.  Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16.

Authors:  G Veress; K Szarka; X P Dong; L Gergely; H Pfister
Journal:  J Gen Virol       Date:  1999-04       Impact factor: 3.891

6.  p53 codon 72 ARG/PRO polymorphism is not related to HPV type or lesion grade in low- and high-grade squamous intra-epithelial lesions and invasive squamous carcinoma of the cervix.

Authors:  A Giannoudis; D A Graham; S A Southern; C S Herrington
Journal:  Int J Cancer       Date:  1999-09-24       Impact factor: 7.396

7.  Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA.

Authors:  P J Snijders; M van Duin; J M Walboomers; R D Steenbergen; E K Risse; T J Helmerhorst; R H Verheijen; C J Meijer
Journal:  Cancer Res       Date:  1998-09-01       Impact factor: 12.701

8.  Comparison of variant-specific hybridization and single-strand conformational polymorphism methods for detection of mixed human papillomavirus type 16 variant infections.

Authors:  R T Emeny; J R Herron; L F Xi; L A Koutsky; N B Kiviat; C M Wheeler
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

9.  Analysis of E2 amino acid variants of human papillomavirus types 16 and 18 and their associations with lesion grade and HLA DR/DQ type.

Authors:  G Terry; L Ho; J Cuzick
Journal:  Int J Cancer       Date:  1997-11-27       Impact factor: 7.396

Review 10.  Molecular events in uterine cervical cancer.

Authors:  S A Southern; C S Herrington
Journal:  Sex Transm Infect       Date:  1998-04       Impact factor: 3.519

View more
  8 in total

1.  Oncogenic human papillomavirus (HPV) type distribution and HPV type 16 E6 variants in two Spanish population groups with different levels of HPV infection risk.

Authors:  M Ortiz; M Torres; L Muñoz; E Fernández-García; J Canals; A I Cabornero; E Aguilar; J Ballesteros; J Del Amo; A García-Sáiz
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

2.  Denaturing high-performance liquid chromatography for detecting and typing genital human papillomavirus.

Authors:  Jianduan Li; Daniela S Gerhard; Zhengyan Zhang; Phyllis C Huettner; Jason Wright; Loan Nguyen; Danielle Lu; Janet S Rader
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

3.  Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.

Authors:  Narayanan Sathish; Priya Abraham; Abraham Peedicayil; Gopalan Sridharan; Subhashini John; George Chandy
Journal:  Mol Diagn       Date:  2004

Review 4.  Human papilloma virus (HPV) and host cellular interactions.

Authors:  Ioannis N Mammas; George Sourvinos; Athena Giannoudis; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2008-05-21       Impact factor: 3.201

5.  Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers.

Authors:  Kate Middleton; Woei Peh; Shirley Southern; Heather Griffin; Karl Sotlar; Tomomi Nakahara; Amira El-Sherif; Lesley Morris; Rashmi Seth; Merilyn Hibma; David Jenkins; Paul Lambert; Nicholas Coleman; John Doorbar
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 6.  Evolutionary and biophysical relationships among the papillomavirus E2 proteins.

Authors:  Dukagjin M Blakaj; Narcis Fernandez-Fuentes; Zigui Chen; Rashmi Hegde; Andras Fiser; Robert D Burk; Michael Brenowitz
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

7.  Whole genome sequencing and evolutionary analysis of human papillomavirus type 16 in central China.

Authors:  Min Sun; Lei Gao; Ying Liu; Yiqiang Zhao; Xueqian Wang; Yaqi Pan; Tao Ning; Hong Cai; Haijun Yang; Weiwei Zhai; Yang Ke
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

8.  Sequence variation in the E2-binding domain of HPV16 and biological function evaluation in Tunisian cervical cancers.

Authors:  Saloua Kahla; Lotfi Kochbati; Samia Hammami; Mohamed Badis Chanoufi; Mongi Maalej; Ridha Oueslati
Journal:  Biomed Res Int       Date:  2014-06-17       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.